Alkermes Plc (ALKS)
34.53
+0.76
(+2.27%)
USD |
NASDAQ |
Apr 17, 16:00
34.59
+0.06
(+0.17%)
Pre-Market: 20:00
Alkermes Free Cash Flow : 480.33M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Assertio Holdings, Inc. | -28.18M |
| Amarin Corp. Plc | 6.744M |
| Jazz Pharmaceuticals Plc | 1.189B |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| Xenon Pharmaceuticals, Inc. | -280.51M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 170.07M |
| Cash from Investing (Quarterly) | 322.35M |
| Cash from Financing (Quarterly) | 10.91M |
| Free Cash Flow Per Share (Quarterly) | 1.003 |
| Free Cash Flow to Equity (Quarterly) | 171.69M |
| Free Cash Flow to Firm (Quarterly) | 180.12M |
| Free Cash Flow Yield | 8.24% |